Clinical Trials Browser

Completed × Breast Neoplasms × ruxolitinib × Clear all

NCT02066532 2023-08-24

Ruxolitinib in Combination With Trastuzumab in Metastatic HER2 Positive Breast Cancer

Phase 1/2 Completed

32 enrolled 13 charts

Breast Neoplasms

NCT02041429 2021-04-21

Ruxolitinib W/ Preop Chemo For Triple Negative Inflammatory Brca

Phase 1/2 Completed

20 enrolled 23 charts

Breast Neoplasms